GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » Buyback Yield %

PELL Bio-Med Technology Co (TPE:6949) Buyback Yield % : -19.07 (As of Dec. 15, 2024)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

PELL Bio-Med Technology Co's current buyback yield was -19.07%.


PELL Bio-Med Technology Co Buyback Yield % Historical Data

The historical data trend for PELL Bio-Med Technology Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co Buyback Yield % Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Buyback Yield %
- - -

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -26.84 -0.65 -0.16

Competitive Comparison of PELL Bio-Med Technology Co's Buyback Yield %

For the Biotechnology subindustry, PELL Bio-Med Technology Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PELL Bio-Med Technology Co's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's Buyback Yield % falls into.



PELL Bio-Med Technology Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

PELL Bio-Med Technology Co's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.8 + 625.768) / 0
=N/A%

PELL Bio-Med Technology Co's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 1.799) * 4 / 4622.37408
=-0.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2024) data.


PELL Bio-Med Technology Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of PELL Bio-Med Technology Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


PELL Bio-Med Technology Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines